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Abstract 
Background: Metabolic engineering of cyanobacteria has enabled photosynthetic conversion of CO2 to value-
added chemicals as bio-solar cell factories. However, the production levels of isoprenoids in engineered cyanobacte-
ria were quite low, compared to other microbial hosts. Therefore, modular optimization of multiple gene expressions 
for metabolic engineering of cyanobacteria is required for the production of farnesyl diphosphate-derived isopre-
noids from CO2.
Results: Here, we engineered Synechococcus elongatus PCC 7942 with modular metabolic pathways consisting of the 
methylerythritol phosphate pathway enzymes and the amorphadiene synthase for production of amorpha-4,11-di-
ene, resulting in significantly increased levels (23-fold) of amorpha-4,11-diene (19.8 mg/L) in the best strain relative 
to a parental strain. Replacing amorphadiene synthase with squalene synthase led to the synthesis of a high amount 
of squalene (4.98 mg/L/OD730). Overexpression of farnesyl diphosphate synthase is the most critical factor for the 
significant production, whereas overexpression of 1-deoxy-d-xylulose 5-phosphate reductase is detrimental to the cell 
growth and the production. Additionally, the cyanobacterial growth inhibition was alleviated by expressing a terpene 
synthase in S. elongatus PCC 7942 strain with the optimized MEP pathway only (SeHL33).
Conclusions: This is the first demonstration of photosynthetic production of amorpha-4,11-diene from CO2 in cyano-
bacteria and production of squalene in S. elongatus PCC 7942. Our optimized modular OverMEP strain (SeHL33) with 
either co-expression of ADS or SQS demonstrated the highest production levels of amorpha-4,11-diene and squalene, 
which could expand the list of farnesyl diphosphate-derived isoprenoids from CO2 as bio-solar cell factories.
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Background
Terpenoids extracted from plants are widely used as 
flavors, fragrances, and medicines. Because these com-
pounds are naturally produced in small quantities, plant 
metabolic engineering has been applied in different 
compartments for the overproduction of target terpe-
noids: mono- and diterpenes and carotenoids in the 
plastids and sesqui- and triterpenes in the cytosol [1, 
2]. The methylerythritol phosphate (MEP) pathway has 
been engineered to enhance the production of volatil-
ized terpenoids [i.e., geranyl diphosphate (GPP)-derived 
monoterpene] such as linalool [3], geraniol [4], and 
limonene [5] by overexpressing the corresponding ter-
pene synthases with engineered promoters in the plas-
tids of carnation, tomato, and tobacco, respectively. On 
the other hand, metabolic engineering studies for higher 
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production of sesquiterpene (i.e., artemisinin) has been 
extensively performed in the cytosol of Artemisia annua 
L. by overexpressing the mevalonate pathway enzymes 
[6], amorpha-4,11-diene synthase (ADS) [7], tran-
scriptional factors to increase the precursor supply and 
repressing enzymes that compete for the precursor using 
the RNA interference-based suppression [8]. Also, syn-
thetic biology has been employed to produce artemisinin 
by reconstructing the heterologous metabolic pathway 
and optimizing the gene expression of ADS and its cogni-
tive enzymes in a non-native fast-growing crop plant (i.e., 
tobacco) [9] or to produce various farnesyl diphosphate 
(FPP)-derived chemicals by altering the catalytic func-
tions of terpene cyclases in A. annua L. [10].
Heterologous terpenoids including mono- and ses-
quiterpenes and carotenoids have also been produced 
in engineered microbes without compartments. For 
microbial production of carotenoids via the MEP path-
way, the strains have been engineered by increasing the 
accumulation of precursors [11] or optimizing pheno-
type through high-throughput screening methods [12, 
13] with expressing heterologous carotenoid biosynthetic 
enzymes. Besides, the heterologous mevalonate pathway 
has been introduced to produce high amounts of het-
erologous monoterpenes such as limonene and pinene 
in Escherichia coli [14, 15] and sesquiterpenes such as 
amorpha-4,11-diene and farnesene in E. coli [16, 17]. The 
recently, engineered Saccharomyces cerevisiae has pro-
duced heterologous artemisinic acid [18, 19], and the E. 
coli-S. cerevisiae co-culture system has been engineered 
to produce oxygenated taxanes and functionalized ses-
quiterpenes (i.e., nootkatone) [20].
As the MEP pathway exists in the plastid of plants, 
cyanobacteria, CO2-fixing photoautotrophs, have the 
sole MEP pathway to form terpenoids and precursors of 
chlorophyll, of which engineering has taken advantage of 
higher rates of photosynthesis in cyanobacteria than land 
plants [21]. Most recent metabolic engineering of cyano-
bacteria has been carried out to directly convert CO2 to 
various biochemicals [22] including isobutyrlaldehyde 
(1.1 g/L) [23], n-butanol (404 mg/L) [24], and 2,3-butan-
ediol (2.3  g/L) [25]. However, the production levels of 
isoprenoids in engineered cyanobacteria showed signifi-
cantly low titers when heterologous terpene synthase was 
expressed only in cyanobacteria: isoprene (approximately, 
0.3  mg/L) [26], the monoterpenes limonene (4  mg/L) 
[27] and β-phellandrene (0.07 mg/L) [28], the sesquiter-
pene bisabolene (0.6 mg/L) [27] and triterpene squalene 
(0.6 mg/L/OD730) [29], and carotenoids (1.1 mg/L/OD730) 
[30]. Because the enzymatic activity of terpene synthase 
is quite low, an optimized cyanobacterial chassis for iso-
prenoid production has not been constructed. Also, a 
majority of cyanobacteria do not produce sesquiterpene 
and triterpene, although cyanobacterial sesquiterpene 
synthases have been recently identified in N2-fixing fila-
mentous cyanobacteria (Nostoc punctiforme PCC 73102 
and Nostoc sp. Strain PCC 7120) [31]. Thus, a modular 
metabolic engineering of cyanobacteria is required to 
provide a synthetic cyanobacterial chassis and to produce 
high levels of GPP-derived or FPP-derived isoprenoids 
production, respectively.
In this work, we describe the metabolic engineering 
of Synechococcus elongatus PCC 7942 as a model sys-
tem with modular expression of the genes encoding the 
MEP pathway enzymes and terpene phosphate synthases 
(TPSs). This engineering allowed for the exogenous pro-
duction of amorpha-4,11-diene and endogenous produc-
tion of squalene directly from CO2.
Results and discussion
Designing modularized pathways for the production 
of amorpha‑4,11‑diene and squalene
S. elongatus PCC 7942 possesses the MEP pathway that 
is used to synthesize isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP) from CO2. In plants 
and eukaryotes, biosynthesis of amorpha-4,11-diene and 
squalene are performed from a substrate FPP or two mol-
ecules of FPP, respectively. Thus, we modularized the 
biosynthesis pathways into two modules (OverMEP and 
TPS) for optimization [16, 32] (Fig. 1a). First, to increase 
the intracellular concentration of the FPP substrate, we 
overexpressed the heterologous genes encoding key 
enzymes in the MEP pathway and an IspA enzyme of 
E. coli using chromosomal integration vectors (pSe1B1s 
[33]) targeting neutral site I (NSI) of S. elongatus PCC 
7942. Four E. coli genes (dxs, dxr, idi, ispA) documented 
to increase lycopene [13, 34, 35] were selected and a 
combinatorial approach of metabolic engineering was 
applied to identify the bottleneck of the cyanobacterial 
MEP pathway toward FPP (Fig. 1b).
For the OverMEP modules, overexpressions of the 
single gene of either the dxs (encoding for 1-deoxy-
d-xylulose-5-phosphate synthase) or idi (encoding for 
isopentenyl diphosphate isomerase) were tested to con-
firm if they are good engineering targets as shown pre-
viously, resulting in the strains SeHL11A and SeHL12A. 
In addition, the dxr gene (encoding for 1-deoxy-d-xylu-
lose 5-phosphate reductase) and/or ispA (encoding for 
farnesyl diphosphate synthase) genes were chosen for 
the overexpression in a combination with the dxs or/and 
idi genes to investigate whether or not Dxr or IspA is the 
rate-limiting enzyme in the MEP pathway. As a result, 
nine recombinant S. elongatus strains were generated for 
the OverMEP modules (Table 1).
Next, a heterologous TPS gene was introduced in S. 
elongatus PCC 7942 at neutral site II (NSII) using the 
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Fig. 1 Modular and metabolic engineering of S. elongatus PCC 7942 for photosynthetic amorpha-4,11-diene and squalene productions from CO2. a 
Heterologous expression of key enzymes derived from E. coli were introduced to direct the carbon flux to the native 2-C-methyl-d-erythritol 4-phosphate 
(MEP) pathway as a module of OverMEP. The second module (TPS terpene synthase) is an enzymatic conversion of farnesyl diphosphate (FPP) to either 
heterologous sesqui- or triterpene as a final carbon sink. Based on the OverMEP strains, heterologous amorphadiene synthase (ADS) and squalene 
synthase (SQS) were expressed, respectively. A molecule of FPP was converted to amorphadiene catalyzed by ADS, or a reductive dimerization of two 
molecules of FPP was catalyzed by SQS to produce squalene. b Schematic diagrams of the construction of S. elongatus PCC 7942 strains that produce 
either amorphadiene or squalene. The heterologous genes dxs, dxs-idi, dxs-dxr-idi, dxr-idi-ispA, dxs-idi-ispA, dxs-dxr-idi-ispA were introduced to a neutral site 
I (NSI) of S. elongatus genomic DNA, respectively. Subsequently, the ADS or SQS genes were introduced to neutral site II (NSII). Each strain was verified by 
PCR using a pair of oligonucleotides shown as red arrows and their sequences are listed in Additional file 1: Table S1. The corresponding DNA fragments 
(1, 2 and 3) are shown in gel images. Also, the DNA sequences were verified correctly. Abbreviations of the corresponding gene are dxs (Ec) 1-deoxy-
d-xylulose-5-phosphate synthase of E. coli, idi (Ec) isopentenyl diphosphate isomerase of E. coli, dxr (Ec) 1-deoxy-d-xylulose 5-phosphate reductase of E. coli, 
ispA (Ec) farnesyl diphosphate synthase (IspA) of E. coli, ADS (Aa) amorpha-4,11-dien synthase of A. annua, SQS (Sc), squalene synthase of S. cerevisiae, G3P 
glyceraldehyde 3-phosphate, DXP 1-deoxy-d- xylulose-5-phosphate, MEP 2-C-methyl-d-erythritol-4-phosphate, CDP-ME 4-diphosphocytidyl-2-C-methyl-
d-erythritol; CDP-MEP 4-diphosphocytidyl-2C-methyl-d-erythritol-2-phosphate, MEcPP 2C-methyl-d-erythritol-2,4-cyclodiphosphate, HMBPP (E)-4-hydroxy-
3-methylbut-2-enyl-diphosphate, IPP isopentenyl diphosphate, DMAPP dimethylallyl diphosphate, FPP farnesyl diphosphate
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second chromosomal integration vector (pSe2B1 k) as a 
TPS module. For the production of amorpha-4,11-diene 
and squalene, the ADS gene [16] encoding for amorpha-
4,11-diene synthase from A. annua and the SQS gene 
[36] encoding for squalene synthase from S. cerevisiae, 
respectively, were also inserted into the chromosome. 
Based on the strains with OverMEP modules, nine and 
three S. elongatus strains were constructed for amorpha-
4,11-diene and squalene, respectively (Table 1).
Cyanobacterial growth for the production 
of amorpha‑4,11‑diene from CO2 with in situ hexadecane 
overlay
To reduce the cellular toxicity of mono- or sesquiterpe-
nes in microbial cell culture, solvent overlays are applied 
for in situ extraction [16, 37]. The dodecane overlay has 
been used to extract limonene and bisabolene from Syn-
echococcus sp. PCC 7002 [27]. The relative activity of the 
cells using a biocompatible organic solvent was correlated 
Table 1 Bacteria strains and plasmids used in this study
a Kmr kanamycin resistance, Spcr spectinomycin resistance, dxs (E. coli) 1-deoxy-d-xylulose-5-phosphate synthase, idi (E. coli) isopentenyl diphosphate isomerase, 
dxr 1-deoxy-d-xylulose 5- phosphate reductase; ispA (E. coli), farnesyl diphosphate synthase (IspA), ADS [16] (A. annua), amorpha-4,11-diene synthase, SQS [36] (S. 
cerevisiae) squalene synthase; (se.co) represents that the gene sequence is codon-optimized to S. elongatus PCC 7942. Note that strains and plasmids were constructed 
in this work unless cited
Strain or plasmid Relevant characteristics
Strains
 E. coli DH5α [60] F−(80d lacZ M15) (lacZYA-argF) U169 hsdR17(r− m+) recA1 endA1 relA1 deoR96
 Amorphadiene-producing E. coli [39] E. coli DH1 harboring pBbA5c-MevT-MBIS plasmid and pADS, Strain 2p
 S. elongatus PCC 7942 Wild type (ATCC 33912)
 SeHL11A S. elongatus NSI::Bb1 s-dxs NSII::Bb2 k-ADS
 SeHL12A S. elongatus PCC 7942 NSI::Bb1 s-idi, NSII::Bb2 k-ADS
 SeHL21A S. elongatus PCC 7942 NSI::Bb1 s-dxs-dxr NSII::Bb2 k-ADS
 SeHL22A S. elongatus NSI::Bb1 s-dxs-idi NSII::Bb2 k-ADS
 SeHL23A S. elongatus PCC 7942 NSI::Bb1 s-dxr-idi NSII::Bb2 k-ADS
 SeHL31A S. elongatus NSI::Bb1 s-dxs-dxr-idi NSII::Bb2 k-ADS
 SeHL32A S. elongatus NSI::Bb1 s-dxr-idi-ispA NSII::Bb2 k-ADS
 SeHL33 S. elongatus NSI::Bb1 s-dxs-idi-ispA
 SeHL33A S. elongatus NSI::Bb1 s-dxs-idi-ispA NSII::Bb2 k-ADS
 SeHL41A S. elongatus NSI::Bb1 s-dxs-dxr-idi-ispA NSII::Bb2 k-ADS
 SeSC00S S. elongatus NSII::Bb2 k-SQS
 SeSC33S S. elongatus NSI::Bb1 s-dxs-idi-ispA NSII::Bb2 k-SQS
 SeSC41S S. elongatus NSI::Bb1 s-dxs-dxr-idi-ispA NSII::Bb2 k-SQS
Plasmidsa
 pSyn_1 (Invitrogen) pUC, Spcr, PNi, NSI target sites
 pSe1Bb1 s-gfp [33] pUC, Spcr, LacI, Ptrc, BglBrick sites, NSI targeting
SyneBrick vector: derived from pSyn_1 vector
 pSe2Bb1 k-gfp [33] pUC, Kmr, LacI, Ptrc, BglBrick sites, NSII targeting
SyneBrick vector
 pSe1Bb1 s-dxs pUC, Spcr, LacI, Ptrc, dxs(se.co) NSI targeting
 pSe1Bb1 s-idi pUC, Spcr, LacI, Ptrc, idi(se.co), NSI target site
 pSe1Bb1 s-dxs-idi pUC, Spcr, LacI, Ptrc, dxs(se.co), idi(se.co), NSI targeting
 pSe1Bb1 s-dxs-dxr pUC, Spcr, LacI, Ptrc, dxs(se.co), dxr(se.co), NSI target site
 pSe1Bb1 s-dxr-idi pUC, Spcr, LacI, Ptrc, dxr(se.co), idi(se.co), NSI target site
 pSe1Bb1 s-dxs-dxr-idi pUC, Spcr, LacI, Ptrc, dxs(se.co), dxr(se.co), idi(se.co), NSI target site
 pSe1Bb1 s-dxr-idi-ispA pUC, Spcr, LacI, Ptrc, dxr(se.co), idi(se.co), ispA(se.co), NSI targeting
 pSe1Bb1 s-dxs-idi-ispA pUC, Spcr, LacI, Ptrc, dxs(se.co), idi(se.co), ispA(se.co)
NSI targeting
 pSe1Bb1 s-dxs-dxr-idi-ispA pUC, Spcr, LacI, Ptrc, dxs(se.co), dxr(se.co), idi(se.co), ispA(se.co), NSI targeting
 pSe2Bb1 k-ADS pUC, Kmr, LacI, Ptrc, ADS(se.co), NSII targeting
 pSe2Bb1 k-SQS pUC, Kmr, LacI, Ptrc, SQS(se.co), NSII targeting
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with the log Poctanol, an indicator of the hydrophobicity 
of the solvent [38]. Here, solvents with log Poctanol > 5.5 
(dodecane, hexadecane, tetradecane) were selected as a 
biocompatible organic solvent for S. elongatus PCC 7942. 
Then, the cellular toxicity of each solvent in S. elongatus 
PCC 7942 was investigated by adding 20 % solvent into 
the culture medium. The growth of S. elongatus was 
slightly inhibited by the addition of dodecane (81.3  % 
growth of the wild type at 5 days), whereas hexadecane or 
tetradecane overlay did not inhibit the cell growth (103 or 
93.6 %) (Fig. 2). Thus, we selected 20 % (v/v) hexadecane 
overlay as in situ extraction of for amorpha-4,11-diene.
With the hexadecane overlay, the growth of the 
recombinant S. elongatus strains (SeHL11A, SeHL12A, 
SeHL31A, SeHL33A) for amorpha-4,11-diene pro-
duction showed the 18, 8, 17, 18  % growth reductions, 
respectively, compared to the wild type (Fig.  3). The 
strain SeHL22A (Dxs-Idi overexpressed) showed severe 
growth inhibition (less than 48  % growth of the wild 
type), although a strain with a single overexpression of 
either dxs or idi (SeHL11A and SeHL12A) grew better 
than SeHL22A. Interestingly, strain SeHL21A, SeHL23A 
SeHL32A, and SeHL41A, where overexpression of Dxr 
was included, showed severe growth inhibition as well 
(<54, 66, 55, 54 % growth of the wild type, respectively).
Photosynthetic production of amorpha‑4,11‑diene 
from CO2
Using in  situ extraction and GC–MS analysis, nine 
recombinant S. elongatus strains with the OverMEP and 
ADS produced amorpha-4,11-diene that was identical 
to the amorpha-4,11-diene produced by recombinant 
E. coli strain 2p [39] and secreted into the hexadecane 
overlay (Fig.  3a, b), whereas the wild type did not pro-
duce amorpha-4,11-diene at all. Strain SeHL11A (Dxs 
overexpressed) and SeHL12A (Idi overexpressed) pro-
duced 0.87 mg/L and 0.84 mg/L of amorpha-4,11-diene, 
respectively. For a combinatorial approach, the co-
expression of Dxs and Idi (strain SeHL22A) resulted in 
an increased level (1.34  mg/L) of amorpha-4,11-diene 
by 1.54- and 1.59-fold over those produced by strain 
SeHL11A and SeHL12A, respectively. The next combi-
natorial engineering was co-expression of Dxr in pre-
viously engineered strains. However, co-expression of 
Dxr with either Dxs or Idi did not increase the levels of 
amorpha-4,11-diene (SeHL21A and SeHL23A) (Fig. 3c). 
Strain SeHL31A (Dxs-Dxr-Idi overexpressed) showed 
even lower levels (0.435 mg/L) than strain SeHL22A by 
2.95-fold. Besides Dxr, co-overexpression of IspA was 
applied to strain SeHL22A and SeHL23A to improve 
the production levels. As a result, strain SeHL32A (Dxr-
Idi-IspA overexpressed) showed 12-fold increased lev-
els of amorpha-4,11-diene (3.59 mg/L) relative to strain 
SeHL23A (Dxr-Idi overexpressed; 0.3 mg/L of amorpha-
4,11-diene). Moreover, strain SeHL33A (Dxs-Idi-IspA 
overexpressed) showed the significantly increased lev-
els of amorpha-4,11-diene (19.8  mg/L) than SeHL22A 
(Dxs-Idi overexpressed) by 14.8-fold. As a full construct, 
SeHL41A (Dxs-Dxr-Idi-IspA overexpressed) showed 
only 2.54  mg/L of amorpha-4,11-diene, 7.8-fold lower 
than SeHL33A. Finally, we engineered S. elongatus PCC 
7942 to produce 19.8 mg/L amorpha-4,11-diene, which 
is the highest levels among cyanobacterial terpenoids 
production reported so far.
Based on the results of the production of amorpha-
4,11-diene and combinatorial engineering of the MEP 
pathway, we identified three key factors to produce high 
levels of amorpha-4,11-diene in S. elongatus PCC 7942 
using the MEP pathway. First, co-overexpression of Dxs 
and Idi from E. coli in S. elongatus PCC 7942 was a good 
engineering choice to enhance the production of amor-
pha-4,11-diene from IPP and DMAPP as shown in other 
studies of isoprenoids [30, 40, 41]. Limonene production 
[40] (0.27 mg/L for 14 days) was increased by 2.3-fold in 
Anavaena sp. PCC 7120 by co-expressing the limonene 
synthase (LS) with synthetic Dxs-Idi from Haematococ-
cus pluvialis and geranyl diphosphate synthase (GPPS) 
from Mycoplasma tuberculosis, compared to the strain 
with limonene synthase only. Also, co-expression of 
the native Dxs-Idi with CrtE (or, GPPS) has led 1.4-fold 
higher production of limonene (0.05  mg/L/d) in Syn-
echocystis sp. PCC 6803 than the parental strain with 
limonene synthase only.
Fig. 2 Cellular toxicity of S. elongatus PCC 7942 with different 
solvents for in situ extraction. Growth (OD730) of the wild type was 
measured with different solvents. 20 % (v/v) of the solvent was added 
into the culture medium at 1 day (indicated in red arrow): no solvent 
overlay (black square), dodecane (red circle), hexadecane (orange 
triangle), and tetradecane (blue inverted triangle). All data are the 
mean ± standard deviation (SD) from the duplicated cultures
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However, co-expression of Dxr negatively impacted 
the levels of amorpha-4,11-diene in S. elongatus PCC 
7942. Engineered strains expressing with Dxr (SeHL21A, 
SeHL23A, SeHL41A) showed lower levels of both amor-
pha-4,11-diene production and cell growth than the paren-
tal strains (SeHL11A, SeHL12A, SeHL33A), respectively. 
Strain SeHL31A showed lower levels of amorpha-4,11-di-
ene than the parental strains (SeHL22A). This negative 
effect has been also observed in Synechococcus leopoliensis 
[42] in which the DMAPP content was not influenced by 
additional overexpression of Dxr. In addition, overexpres-
sion of Dxr has not shown much impact on metabolic bal-
ances of the MEP pathway in Arabidopsis [43, 44]. As little 
is known about the multiple levels of the MEP pathway reg-
ulation in S. elongatus PCC 7942, it is not clear why overex-
pression of Dxr negatively affected production. Fine-tuning 
Fig. 3 Photosynthetic production of amorpha-4,11-diene from CO2 in engineered S. elongatus PCC 7942 strains. a In situ-extracted samples from 
hexadecane overlay using engineered E. coli strain [39] (peak 1) and S. elongatus strains (peak 2) were analyzed using GC–MS. The internal standard 
(IS) is caryophyllene. b Mass spectra and retention times of amorpha-4,11-diene from either the E. coli strain [39] or engineered S. elongatus strains. 
RT retention time (in min). c Growth (square) and production of amorpha-4,11-diene (bar) by engineered S. elongatus strains: SeHL11A, SeHL22A, 
SeHL31A, SeHL32A, SeHL33A, and SeHL41A. All data are the mean ± standard deviation (SD) from the triplicated cultures
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gene expression, such as with the RBS calculator [45] to 
fine-tune production or by adding protein degradation tags 
[46] to Dxr to fine-tune degradation, may be required to 
balance the gene expression of Dxr for the MEP pathway 
flux, because E. coli Dxr has lower Km value (30 µM) and 
faster kcat (100 s−1) than the cyanobacterial enzyme (Km of 
134 µM and kcat of 5 s−1) [47].
Overexpression of E. coli’s IspA was the most crucial 
factor to increase amorpha-4,11-diene production in 
S. elongatus PCC 7942, where the best producer, strain 
SeHL33A, showed 22.8-fold higher production than the 
first engineered strain (SeHL11A) without growth retar-
dation. Whereas E. coli has been engineered with IspA 
for isoprenoid production [17, 35], overexpression of Idi 
and Dxs was regarded as a key factor to improve produc-
tion [35, 48, 49]. There have been no FPP synthase activi-
ties experimentally verified in S. elongatus PCC 7942. 
Thus, heterologous expression of sesquiterpene synthases 
without co-expression of FPP synthases in cyanobacteria 
could produce relatively low amounts of sesquiterpe-
nes [27, 50] compared to the amounts of monoterpenes 
produced when monoterpene synthases are expressed 
(i.e., limonene [40, 41]). Overall, multi-omics technolo-
gies that integrate metabolomics, proteomics and net-
work-modeling will allow understanding the complex 
regulation and metabolic aspects including identifica-
tion of the rate-limiting step in metabolic engineering of 
cyanobacteria for isoprenoid productions [51]. Further-
more, directed evolution and protein fusions of IspA to 
GPPS or TPS [17, 52] of E. coli could provide a chance to 
improve production of sesquiterpenes with chain length 
specificity. Besides IspA of E. coli, overexpression of IspA 
from different sources could be also useful to engineer 
cyanobacteria.
Photosynthetic production of squalene from CO2
To determine whether the OverMEP module can be used 
as a basis for isoprenoid production, we engineered the 
Fig. 4 Photosynthetic production of squalene from CO2 in engineered S. elongatus PCC 7942 strains. a Cell pellets from engineered S. elongatus 
strains were extracted using a mixture of chloroform and methanol. Authentic squalene standard (peak 1) and extracted samples (peak 2) were 
analyzed with GC–MS. The internal standard (IS) is 1-phenyloctadecane. b Mass spectra and retention times of authentic squalene or the samples 
from engineered S. elongatus strains. RT retention time (in min). c Growth (OD730) of wild-type (black square) and engineered S. elongatus strains: 
SeSC00S (red circle), SeSC33S (blue triangle) and SeSC41S (cyan upper triangle) strain. d Production (mg/L/OD730) of squalene from wild-type and the 
engineered S. elongatus SeSC00S, SeSC33S, SeSC41S. All data are the mean ± standard deviation (SD) from the triplicated cultures. ND not detected
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strain SeHL33 (Dxs-Idi-IspA overexpressed) with co-
expression with SQS as another TPS module, since SQS 
catalyzes the formation of squalene, a triterpene synthe-
sized from two molecules of FPP. Three recombinant S. 
elongatus strains were constructed for the production of 
squalene (Fig.  4). The wild-type S. elongatus PCC 7942 
strain did not produce squalene, and a very low amount of 
squalene (0.0001 mg/L/OD730) was produced in a cell by 
expressing SQS alone (SeSC00S). Similar to SeHL33A, the 
SeSC33S strain (Dxs-Idi-IspA overexpressed) produced 
a high amount of squalene in S. elongatus PCC 7942 
(4.98  mg/L/OD730 ±0.90), which was 50,000-fold higher 
than the strain SeSC00S and the highest levels reported 
so far in cyanobacteria. In the strain SeSC41S (Dxs, 
Dxr, Idi, and IspA overexpressed), the squalene content 
(0.13 mg/L/OD730 ±0.01) was reduced by 38.3-fold com-
pared to SeSC33S. The increased or decreased levels were 
consistent with the previous results of amorpha-4,11-di-
ene production using the SeHL33 or SeHL41 module, 
respectively. Thus, squalene production studies also sup-
port that overexpression of either Dxr was a negative fac-
tor or IspA was the most crucial factor in cyanobacteria to 
increase FPP-derived isoprenoids such as sesquiterpenes 
and triterpenes along with overexpression of Dxs and Idi, 
respectively. With respect to the enhanced production of 
amorpha-4,11-diene and squalene, the SeHL33 with mod-
ularized OverMEP proved to be orthogonally functional 
and expandable to produce other sesquiterpenes or triter-
penes with the corresponding TPS’s.
Fig. 5 Growth and levels of chlorophyll a contents from engineered 
cyanobacteria. a Growth inhibition of the recombinant strains with 
an OverMEP module, but a TPS. Cyanobacterial cells were cultivated 
for 7 days with 5 % CO2 bubbling. Growth of the strains producing 
amorphadiene (SeHL33A; black square), squalene-producing strain 
(SeSC33S; red circle), and an OverMEP strain lacking a TPS (SeHL33; 
blue triangle) was measured at OD730. All data are the mean ± stand-
ard deviation (SD) from the triplicated cultures. b Levels of Chlo-
rophyll a contents (mg/L/OD730) from engineered cyanobacteria. 
Chl a contents were measured by a spectrophotometric assay from 
cyanobacterial cells cultivated for 2 and 8 days. Strains are presented 
as WT (black bar), SeHL33A (gray bar), SeSC33S (blue bar), and SeHL33 
(green bar). All data are the mean ± standard deviation (SD) from the 
triplicated cultures
Fig. 6 Production comparisons of various isoprenoids from engi-
neered cyanobacteria. Specific production over 48 h culture (mg/L/
OD730) of amorpha-4,11-diene and squalene (this work in black bar) 
were compared with the previous results (in gray bar) as the follow-
ing: (Group I: the proof of concept; bisabolene from Synechococcus 
sp. PCC 7002 [27], squalene from Synechocystis sp. PCC 6803 [29], 
limonene from Synechococcus sp. PCC 7002 [27]) (Group II: Pathway 
optimization; β-phellandrene from Synechocystis sp. PCC 6803 [28], 
carotenoid from Synechocystis sp. PCC 6803 [30], isoprene from Syn-
echocystis sp. PCC 6803 [26]), and (Group III: Protein fusion with TPS 
and pathway optimization combined; β-phellandrene from Synecho-
cystis sp. PCC 6803 [55, 57], isoprene from Synechocystis sp. PCC 6803 
[56]). The number on the bar indicates specific production over a 48 h 
culture. The detailed information is described in “Conclusion” and in 
the Additional file 1: Table S1. MVA Mevalonate
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Alleviating the cyanobacterial growth inhibition 
by expressing a terpene synthase in S. elongatus PCC 7942 
strain with the optimized MEP pathway only (SeHL33)
To expand the FPP-derived isoprenoids production 
using cyanobacterial strain expressing Dxs, Idi, and IspA 
(SeHL33), we compared the strain SeHL33 as a basis with 
amorphadiene-producing SeHL33A and squalene-pro-
ducing SeSC33S. Previously, the toxicity of FPP, which 
can accumulate in engineered E. coli, has been allevi-
ated by increasing the activity of the terpene cyclase [16]. 
Thus, we speculated that the strain SeHL33 could also 
accumulate FPP. In absence of cyanobacterial analysis of 
proteomics and intracellular FPP accumulation patterns 
[53], we examined whether or not the strain SeHL33 
showed a growth defect due to possible FPP toxicity. As 
results, the cultures of three recombinant S. elongatus 
strains (strains SeHL33, SeHL33A and SeSC33S) were 
monitored, showing that the growth of SeHL33 was sig-
nificantly lower than that of SeHL33A and SeSC33S 
(Fig. 5a). Moreover, cyanobacterial growth can be meas-
ured indirectly using the changes of chlorophyll content 
[54]. Also, the biosynthesis of Chl a is connected to the 
engineered MEP pathway via geranylgeranyl diphos-
phate. Chlorophyll a contents of the wild-type, SeHL33A, 
SeSC33S, or SeHL33 strains were determined at 2 and 
8  days, resulting in that the Chl a content of the strain 
SeHL33 at 8 days was significantly lower than the Chl a 
contents of other strains (Fig. 5b). Thus, low Chl a con-
tent (mg/L/OD730) of the SeHL33 strain might be related 
to the growth defect of of SeHL33.
However, our engineered strain SeHL33 with either 
an ADS or SQS did not show the negative effect on the 
growth. Thus, alleviation of the cellular toxicity in the 
engineered MEP pathway with co-expression of terpene 
synthase in this study was consistent with the previous 
result in engineered E. coli [16]. Furthermore, genome-
wide transcriptomics approach could be employed using 
the strain SeHL33 to increase the levels of isoprenoid 
production by identifying the stress-response promot-
ers for engineering dynamic pathway regulation [53]. 
In-depth metabolite analysis (or metabolomics) for the 
strains could be also needed to understand the bottle-
necks and to improve isoprenoid biosynthesis. Since 
our engineered strains with a modular OverMEP and 
either an ADS or SQS did not show a negative effect on 
the growth, we could expand engineering of SeHL33 
with different TPSs converting FPP to various sesqui- or 
triterpenes.
Conclusion
Beyond the proof of concept of isoprenoid produc-
tions in cyanobacteria [27, 29], the effort of metabolic 
engineering of cyanobacteria expanded the list of 
products from CO2 as bio-solar cell factories in this 
study. Although isoprenoid titers may be influenced 
by the type of strains, the characteristics of TPS and 
culture conditions and the high levels of amounts of 
amorpha-4,11-diene and squalene were produced in 
this work when pathway optimization was a main strat-
egy of metabolic engineering for isoprenoid produc-
tion (Fig. 6; Additional file 1: Table S1). Combined with 
the pathway optimization, increasing the low activity 
(slow kcat) of terpene synthase has been shown to be 
very crucial for the enhanced production of isopre-
noid in cyanobacteria [55, 56]. Recently, CpcB as fusion 
partner or a key MEP enzyme (Idi) was fused to a ter-
pene synthase that resulted in significantly high levels 
of production of β-phellandrene [55, 57] and isoprene 
[56], respectively. The engineered strains for isoprene 
production showed the 40 % of photosynthetically fixed 
carbon fluxes toward isoprenoid biosynthesis pathways. 
However, there is still much room left for engineering 
cyanobacteria to improve the titers, compared to other 
microbial hosts (293  mg/L/OD600 of amorphadiene in 
E. coli [58] and 242 mg/L/OD600 of amorphadiene in S. 
cerevisiae [18]; 150 mg/L and 55 mg/gDW of squalene 
in E. coli [59]). For example, installing efflux pump pro-
tein could improve the amorphadiene in cyanobacteria, 
of which screening strategy has been successful in E. 
coli [60].
To our knowledge, our optimized modular OverMEP 
strain (SeHL33) with either co-expression of ADS or SQS 
demonstrated the highest production levels of amorpha-
4,11-diene and squalene from CO2.
Methods
Chemicals and reagents
All chemicals were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) unless otherwise specified. Restriction 
enzymes, Phusion DNA polymerase, and ligases were 
purchased from Fermentas (Thermo Fisher Scientific 
Inc., MA, USA).
Plasmids construction
E. coli strain DH5α [61] was used for gene cloning 
and grown in Luria–Bertani medium (containing per 
liter: 10  g tryptone, 5  g yeast extract, and 10  g NaCl) 
at 37  °C, and when appropriate the medium was sup-
plemented with 50  μg/mL kanamycin or 100  μg/mL 
spectinomycin. All plasmids were derived from Syn-
eBrick expression plasmids (standard vectors for 
chromosomal integration at the neutral site I (NSI) 
or II (NSII) using a pSyn_1; pSe1Bb1  s-gfp [33] and 
pSe2Bb1 k-gfp [33]) using the BglBrick standard clon-
ing method [62] (Table 1). To overexpress key enzymes 
of the MEP pathway, the dxs gene encoding for 
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1-deoxy-d-xylulose-5-phosphate synthase (Dxs), the 
dxr gene encoding for 1-deoxy-d-xylulose 5- phosphate 
reductase (Dxr), the idi gene encoding for isopentenyl 
diphosphate isomerase (Idi), and the ispA gene encod-
ing for farnesyl diphosphate synthase (IspA) from E. 
coli were codon-optimized to S. elongatus PCC 7942 
using Gene Designer 2.0 software (DNA2.0, Menlo 
Park, CA, USA) with a codon usage matrix of S. elon-
gatus PCC 7942 and synthesized and cloned into a 
pSe1Bb1 s vector (targeting at NSI). For production of 
amorpha-4,11-diene and squalene, the ADS gene [16] 
encoding for amorpha-4,11-diene synthase from A. 
annua and the truncated SQS gene [36] encoding for 
squalene synthase from S. cerevisiae were also synthe-
sized and cloned into a pSe2Bb1 k vector (targeting at 
NSII), respectively.
Cyanobacterial strain construction and transformation
Transformation of S. elongatus PCC 7942 was per-
formed as described previously [63]. The cyanobacte-
rial strains were transformed by incubating cells at a 
mid-log phase (OD730 of 1–2) with 100  ng of plasmid 
DNA for 24 h in the dark. The mixed culture was then 
spread on BG-11 plates supplemented with appropri-
ate antibiotics for selection of successful recombination. 
For selection and culture maintenance, 10 μg/mL spec-
tinomycin or/and 10 μg/mL kanamycin were added into 
BG-11 agar plates and the BG-11 medium where appro-
priate. Sub-culture of a single colony was performed 
to prevent chromosomal segregation. The strains were 
confirmed by PCR to verify chromosomal integration 
of targets into either the NSI or NSII (Fig.  1) and the 
DNA sequences were also correctly verified using a 
pair of oligonucleotides (Additional file 1: Table S1). S. 
elongatus PCC 7942 strains were constructed by trans-
forming the overexpressed MEP strains with plasmids 
pSe2Bb1 k-ADS and pSe2Bb1 k-SQS, respectively. Gen-
otypes of recombinant S. elongatus strains are listed in 
Table 1.
Growth condition for amorphadiene and squalene 
from engineered cyanobacteria
S. elongatus PCC 7942 derivatives for production of 
amorpha-4,11-diene and squalene were cultivated at 
30 °C in the 100 mL culture under continuous fluorescent 
light (100  µmol photons/m2/s) in BG-11 medium sup-
planted with 10 mM MOPS (pH 8.0). 5 % (v/v) CO2 gas 
was supplied at a constant flow rate of 10  mL/min into 
the medium. 10  μg/mL spectinomycin or/and 10  μg/
mL kanamycin were supplemented for selection pres-
sure. 0.5  mM isopropyl-β-d-1-thiogalactopyranoside 
(IPTG) was supplemented into the culture medium at 
24  h after inoculation for inductions. Especially, 20  % 
(v/v) hexadecane was added for in  situ extraction of 
amorphadiene.
Quantification of amorpha‑4,11‑diene and squalene
Quantification of amorpha-4,11-diene (mg of amorpha-
4,11-diene per liter of culture volume) was performed 
as described previously [16, 64]. The hexadecane layer 
in the culture was collected and diluted 1:10 with ethyl 
acetate containing 5  μg/mL of (-)-trans-caryophyllene 
as an internal standard. Hexadecane/ethyl acetates 
extracts were analyzed using a GC–MS (Agilent 6890 
gas chromatograph interfaced with an Agilent 5975 
MSD). The extracted sample (1  μL) was injected in 
split mode (10:1) at an injector temperature of 220  °C 
and separated using an Ultra-2 capillary column 
(33  m  ×  0.2  mm i.d., 0.11  μm film thickness; Agilent 
Technologies). The initial oven temperature was 100 °C 
for 3  min and ramped up to 200  °C at 7  °C/min for a 
total run time of 17.29  min. Helium (99.9999  %) was 
used as the carrier gas (1.0 mL/min. constant flow at an 
oven temperature of 150  °C). The ion source tempera-
ture was 220 °C. The mass spectrometer was operated at 
70 eV in the electron ionization mode with selected ion 
monitoring (SIM) and the mass range was 35–400 m/z. 
Biosynthetic amorphadiene was obtained from the cul-
ture of E. coli DH1 harboring the pBbA5c-MevT-MBIS 
plasmid and pADS (Strain 2p) [39].
For quantification of squalene, the extraction method 
was performed as described previously [29] with slight 
modification. 50 mL of the culture was used for extrac-
tion. After centrifugation at 3000×g for 10 min, the cell 
pellets were re-suspended with a 2 mL mixture of chlo-
roform and methanol (1:2 ratio) and liquid–liquid extrac-
tion occurred for 30  min at room temperature. After 
additional centrifugation (16,000×g for 3 min), the super-
natants (200 μL) were collected and the samples supple-
mented with 20 μg/mL of 1-phenyloctadecane as internal 
standard were analyzed using a GC–MS. The extracted 
sample was analyzed using a gas chromatography 
equipped with a gas chromatography–mass spectrom-
etry (GC-MSD; Agilent Technologies, Santa Clara, CA) 
equipped with a U2 capillary column (33 m × 0.25 mm, 
film thickness 0.25  mm, Agilent Technologies, Santa 
Clara, CA), carrier gas: He (1  mL/min), oven tempera-
ture: 90–290 °C (increase rate 6 °C/min). The mass spec-
trometer was operated at 70 eV in the electron ionization 
mode with selected ion monitoring (SIM; 69  m/z) and 
mass range was 35–400 m/z.
Measurement of chlorophyll a
Cyanobacterial cell cultures (1.5 mL) were harvested and 
the pigments of cell pellets were extracted in 100  % ace-
tone at 50  °C for 15  min. After centrifugation (16,000×g 
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for 3  min), the pigment extract was analyzed for chloro-
phyll a (Chl a) by following the previous spectrophoto-
metric assay [65]. The supernatant was obtained and the 
absorbance was measured at 400–700 nm on Cary 60 UV–
Vis spectrophotometer (Agilent technologies, CA, USA).
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